Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.

2018 ◽  
Author(s):  
Juan Carlos Percovich ◽  
Jose Atencia ◽  
Rogelio Garcia ◽  
Marcel Sambo ◽  
Montserrat Blanco ◽  
...  
2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Tine Gregersen ◽  
Nanna Holt ◽  
Henning Gronbaek ◽  
Ida Vogel ◽  
Lars J. Jørgensen ◽  
...  

Neuroendocrine tumors are rare tumors primarily located in the gastrointestinal tract. Goblet cell carcinoid is a rare subgroup of neuroendocrine tumors located in the appendix. Neurofibromatosis type 1 is an autosomal dominant disorder caused by a mutation in theNF1gene. Patients with neurofibromatosis type 1 have an increased incidence of typical neuroendocrine tumors, but it is unknown if this is the case with goblet cell carcinoids. We describe a patient with both neurofibromatosis type 1 and goblet cell carcinoid, that according to literature would occur in 0.00017 per million per year. This may suggest a previously unknown association between neurofibromatosis type 1 and goblet cell carcinoids.


2018 ◽  
Vol 31 (10) ◽  
pp. 1532-1538 ◽  
Author(s):  
Michaël Noë ◽  
Antonio Pea ◽  
Claudio Luchini ◽  
Matthäus Felsenstein ◽  
Stefano Barbi ◽  
...  

2008 ◽  
Author(s):  
Jonathan M. Kurss ◽  
Anna E. Craig ◽  
Jennifer Reiter-Purtill ◽  
Kathryn Vannatta ◽  
Cynthia Gerhardt

2011 ◽  
Vol 42 (01) ◽  
Author(s):  
F. Mainberger ◽  
N. Jung ◽  
M. Zenker ◽  
I. Delvendahl ◽  
U. Wahlländer ◽  
...  

2014 ◽  
Vol 45 (S 01) ◽  
Author(s):  
J. Keppler ◽  
A. Fiedler

Sign in / Sign up

Export Citation Format

Share Document